In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and recent reports about the New World screwworm. Dr. Morice also shares insights on building an innovation strategy that delivers meaningful organizational value.

• PAMA reform update (00:40): Dr. Morice discusses the status of the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act and PAMA.
• Tracking the New World screwworm (02:24): Learn about recent cases of the New World screwworm, why this parasitic fly is problematic, and how sterile insects help contain it.
• Developing an innovation strategy that drives value (04:49): Discover lessons from Dr. Morice’s experience developing a strategic approach to innovation that delivers meaningful outcomes and impact.

Resources

• 4 steps to establishing a new approach to innovation

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss “rabbit fever” cases in New York and strategies for responding to industry trends. Later, Dr. Pritt welcomes Mary Jo Williamson, Mayo Clinic Laboratories’ chief administrative officer, to share practical strategies for leading teams through periods of rapid change.

• Strategies for making strategic progress amid disruption (00:29): Discover practical insights from a recent Forbes article by Dr. Morice on identifying healthcare industry disruptors and determining how organizations should respond.
• A rare tick-borne illness (07:21): Learn about suspected cases of the rare tick-borne illness tularemia, also known as "rabbit fever.”
• Leading through change (09:02): Williamson shares lessons from more than three decades of healthcare leadership, offering practical guidance for helping teams navigate change with confidence and purpose.

Resources

• Forbes: Understanding healthcare industry disruptors and what comes next
• Tick-borne disease: An expanding threat
• Five steps to manage change in an outreach laboratory
• Mary Jo Williamson talks resiliency and agility on Fierce Healthcare podcast
• Mary Jo Williamson shares strategic investment insights with Modern Healthcare

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the Protecting Access to Medicare Act (PAMA) and a recent Cyclospora outbreak making headlines. Later, Dr. Pritt welcomes Juliana Perez Botero, M.D., a Mayo Clinic hematologist, to explore innovative testing approaches for bleeding disorders.

• PAMA data collection and reform (01:05): With data collection for PAMA underway, Dr. Morice shares the latest on potential updates to the law.
• Cyclospora outbreak (05:45): Get a microbiologist’s perspective on the recent Cyclospora outbreak and learn practical steps to help reduce your risk of infection.
• The value of laboratory testing for bleeding disorders (08:37): Discover why laboratory testing plays a critical role in the diagnosis and management of patients with bleeding disorders.
• Innovation for bleeding disorder testing (12:56): Learn how genotype assays are enhancing patient care and how advances in nanotechnology and collaborative research are opening new possibilities for the future.

Resources

• Mayo Clinic Classical Hematology Conference
• Bleeding disorders: The right test at the right time
• Cyclospora Stain, Feces (Mayo ID: CYCL)

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent artificial intelligence (AI) initiatives in the news. She then welcomes Jane Hermansen, manager of Mayo Clinic Laboratories’ Outreach Program, to discuss the value of outreach programs in strengthening laboratories and supporting broader healthcare systems.

• AI’s potential and limitations (00:01): Learn what’s next and the challenges that remain as Drs. Pritt and Morice discuss recent stories about AI in healthcare.
• Value of outreach (07:30): Discover how laboratory outreach programs support their organizations, delivering benefits that range from improved patient care to lower testing costs and growth across health system service lines.
• Getting the most from outreach (15:54): Learn the three most important things lab leaders can do to get the greatest value from their outreach program.
• The future of outreach (17:53): Get insights on how outreach may evolve in the coming years as healthcare changes.

Resources

• Fortune: A decade after the ‘Godfather of AI’ said radiologists are obsolete, salaries are $571K and growing
• “Answers From the Lab” podcast: Digital Advances: What's Next for Clinical Diagnostics?
• Personalized pathways through digital diagnostics: A Q&A with Chris Garcia, M.D.
• Outreach & Business Solutions
• Own your lab: Hospital-owned labs generate long-term financial and clinical value
• Leveraging the Laboratory Conference

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent industry news and how clinical diagnostics are powering more personalized care. Together, they explore:

• Point-of-care testing in outbreak response (00:29): Hear about the potential and limitations of point-of-care testing during disease outbreaks.
• A rare type of Lyme disease (02:46): Learn about the spread of the second known pathogen to cause Lyme disease in the U.S.
• The evolution of AI (04:50): Dr. Morice shares insights from a recent conference, highlighting the shift from discussing artificial intelligence’s potential to scaling real-world clinical applications.
• Personalized medicine and diagnostics (06:07): Discover how clinical diagnostics are driving personalized medicine and how data will shape its future.

Resources

• Four ways diagnostics are driving more personalized care
• "Answers From the Lab" podcast: Advancing Precision Medicine Through Therapeutic Tests
• "Answers From the Lab" podcast: Risks Increase as Ticks, Mosquitoes, and Similar Vectors Spread
• Therapeutics testing: Discover the differences

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss updates on the Protecting Access to Medicare Act (PAMA) and other policy changes affecting clinical diagnostics. Later, Dr. Pritt welcomes Ann Moyer, M.D., Ph.D., a molecular genetic pathologist at Mayo Clinic and chair of the hereditary genetics practice, to explore how precision therapeutics are improving cancer treatments.

• PAMA update (00:01): Get the latest on PAMA as the first data collection period begins, including ongoing efforts to advance the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
• Policy changes influencing diagnostics (04:09): Learn how evolving reimbursement policies for blood-based cancer screening and a proposed CLIA modernization bill may impact the field.
• Pharmacogenomic tests improving cancer care (08:14): Discover how pharmacogenomics are benefiting patients with cancer, the benefits of medication-based testing, and how this field is advancing.

Resources

• CMS: CLFS & PAMA reporting and resources
• Precision Oncology Therapeutics: Personalized cancer treatment
• Answers From the Lab: Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.
• Answers From the Lab: Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, speaks with William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, about Ebola, hantavirus and takeaways from a recent healthcare conference. Later, she welcomes Elli Theel, Ph.D., a microbiologist in Mayo Clinic’s Department of Laboratory Medicine and Pathology, to explore vector-borne diseases.

• Top industry topics (00:04): Dr. Morice highlights key topics from a recent major healthcare conference, including AI and payment reform.
• Infectious diseases in the news (04:04): Overview of hantavirus, Ebola, and why laboratory medicine is important during outbreaks.
• Growing prevalence of vector-borne diseases (06:48): Insights on the growing prevalence of vector-borne diseases.
• Testing options (09:45): Understand the different types of testing available for pathogens and when it is best to use each one.
• Innovation and discovery (17:05): Discover emerging pathogens and advances in detection.
• Protect yourself (19:41): Learn easy ways to protect yourself and your family from vector-borne diseases.

Note: Information in this post was accurate at the time of its posting.

Resources

• Forbes: Is hantavirus an emerging threat? What you need to know
• Vector-borne diseases by geographic region
• Vector-borne diseases: The right tests for detection and diagnosis
• Learn the ABCs of ticks

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes Brad Karon, M.D., Ph.D., division chair for Mayo Clinic's Clinical Core Laboratory Services and a member of the laboratory and pathologist stewardship team, to discuss laboratory stewardship strategies and why they matter.

• Why lab stewardship is important (00:44): How improved test utilization benefits laboratories, healthcare systems, and patients.
• Strategies for promoting lab stewardship (03:40): Proven approaches for improving appropriate test utilization.
• How industry disrupters will change stewardship efforts (09:33): How artificial intelligence and other emerging disruptors may reshape lab stewardship efforts.

Note: Information in this post was accurate at the time of its posting.

Resources

• Froedtert and the Medical College of Wisconsin: Promoting laboratory stewardship through clinical decision support
• Five steps to optimizing your outreach test menu
• Hospital-owned labs generate long-term financial and clinical value